Search

everythinglearnresearchcommunity

for

Search:↓

New alopecia treatments aim for better results and fewer side effects.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Some cancer treatments can cause permanent hair loss.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Isotretinoin was not effective in treating facial lichen planopilaris.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.